Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
- 3.9k Downloads
The bioavailability of a development candidate active pharmaceutical ingredient (API) was very low after oral dosing in dogs. In order to improve bioavailability, we sought to increase the dissolution rate of the solid form of the API. When traditional methods of forming salts and amorphous material failed to produce a viable solid form for continued development, we turned to the non-traditional approach of cocrystallization.
A crystal engineering approach was used to design and execute a cocrystal screen of the API. Hydrogen bonding between the API and pharmaceutically acceptable carboxylic acids was identified as a viable synthon for associating multiple components in the solid state. A number of carboxylic acid guest molecules were tested for cocrystal formation with the API.
A cocrystal containing the API and glutaric acid in a 1:1 molecular ratio was identified and the single crystal structure is reported. Physical characterization of the cocrystal showed that it is unique regarding thermal, spectroscopic, X-ray, and dissolution properties. The cocrystal solid is nonhygroscopic, and chemically and physically stable to thermal stress. Use of the cocrystal increased the aqueous dissolution rate by 18 times as compared to the homomeric crystalline form of the drug. Single dose dog exposure studies confirmed that the cocrystal increased plasma AUC values by three times at two different dose levels.
APIs that are non-ionizable or demonstrate poor salt forming ability traditionally present few opportunities for creating crystalline solid forms with desired physical properties. Cocrystals are an additional class of crystalline solid that can provide options for improved properties. In this case, a crystalline molecular complex of glutaric acid and an API was identified and used to demonstrate an improvement in the oral bioavailability of the API in dogs.
Key wordsbioavailability cocrystal crystal engineering intrinsic dissolution rate pharmacokinetics solubility
The authors thank Dr. Ken Hardcastle at the Emory University Chemistry Department X-Ray Diffraction Center for collecting and solving the single crystal structure of the cocrystal. The authors also acknowledge the support of Drs. Phil Goliber and Leah Lipsich of Purdue Pharma L. P.
- 2.Calculated using Advanced Chemistry Development (ACD/Labs) Software Solaris V4.67 (1994–2005 ACD/Labs).Google Scholar
- 4.S. L. Childs, L. C. Chyall, J. T. Dunlap, V. N. Smolenskaya, B. C. Stahly, and G. P. Stahly. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoexetine hydrochloride with benzoic, succinic, and fumaric acids. J. Am. Chem. Soc. 126:13335–13342 (2004).PubMedCrossRefGoogle Scholar
- 20.P. Vishweshwar, A. Nangia, and V. M. Lynch. Supramolecular synthons in phenol-isonicotinamide adducts. Crystengcomm.: 164–168 (2003).Google Scholar
- 21.M. C. Etter. Aggregate structures of carboxylic acids and amides. Isr. J. Chem. 25(3–4):312–319 (1985).Google Scholar
- 22.SMART Version 5.55, 2000, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.Google Scholar
- 23.SAINT Version 6.02, 1999, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.Google Scholar
- 24.SHELXTL V5.10, 1997, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.Google Scholar
- 25.A. J. C. Wilson (ed.), International Tables for X-ray Crystallography, Volume C. Kynoch, Academic, Dordrecht, 1992, Tables 184.108.40.206 (pp. 500–502) and 220.127.116.11 (pp. 219–222).Google Scholar
- 26.C. G. S. Wermuth. P. H. Handbook of Pharmaceutical Salts; Properties, Selection, and Use (P. H. W. Stahl, C. G., ed.). Verlag Helvitica Chimica Acta, Zurich and Wiley-VCH: Weinheim, 306 (2002).Google Scholar
- 27.W. C. McCrone, Jr., Fusion Methods in Chemical Microscopy. Interscience, New York, 1957.Google Scholar
- 29.M. Kunhert-Brandstaetter. 40 Years of Kofler methods. Pharma Int. (Engl. Ed.) 5:5–11 (1971).Google Scholar